If you are a student, recent graduate or alumni interested in exploring a career in the biotechnology, pharmaceutical and life sciences industries, you are in the right place! Register today to start your job search and be contacted by employers nationwide looking for you! It only takes a few minutes and you will be on your way to the perfect job!
Sunday, September 20, 2009
You can’t open a newspaper today without reading about the need for health care reform. Costs are skyrocketing, and people are demanding access to high quality care and new medicines. How can a system balance the need to reduce costs with the desire for new therapies? .
Advertisement
Some of our local policymakers are looking to biologics as part of the answer. Biologics are medicines made from living cells that treat debilitating diseases such as cancer, HIV/AIDs, Alzheimer’s disease and multiple sclerosis. Because the cutting-edge technology used to create biologics is far more complex than the process used to manufacture chemical-based drugs like aspirin, there is currently no regulatory pathway for approving “biosimilars,” or medicines that are similar to, but not the same as innovator biologics.Read Full Article
posted in: News, Washington DC
Phoenix • Tucson • Palm Springs • Sacramento • San Diego • San Francisco • San Jose • Denver • Jacksonville • Miami • Orlando • Tampa • Atlanta • Chicago • Indianapolis • Kansas City • Louisville • New Orleans • Boston • Baltimore • Detroit • Grand Rapids • Minneapolis • Charlotte • Raleigh • Omaha • Atlantic City • Las Vegas • Reno • Buffalo • New York City • Cincinnati • Cleveland • Toledo • Tulsa • Portland • Philadelphia • Pittsburgh • Myrtle Beach • Memphis • Nashville • Austin • Dallas • Houston • San Antonio • Salt Lake City • Richmond • Seattle • Spokane
